ProfileGDS4718 / 203787_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 73% 92% 56% 67% 23% 34% 68% 69% 65% 66% 77% 46% 39% 50% 65% 72% 33% 31% 50% 57% 66% 66% 64% 63% 48% 63% 29% 68% 53% 78% 70% 73% 72% 72% 47% 47% 76% 75% 90% 75% 58% 67% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5864266
GSM549102patient 115, normal, homogenized [OPG study]7.087573
GSM549104patient 119, normal, homogenized [OPG study]9.6027392
GSM549108patient 138, normal, homogenized [OPG study]5.8921856
GSM549119patient 077, normal, homogenized [OPG study]6.5798567
GSM549133patient 032, cancer, homogenized [OPG study]4.2137923
GSM549139patient 042, cancer, homogenized [OPG study]4.7028734
GSM549099patient 107, normal, homogenized [OPG study]6.6938568
GSM549109patient 139, normal, homogenized [OPG study]6.7865369
GSM549110patient 046, normal, homogenized [OPG study]6.4907765
GSM549114patient 063, normal, homogenized [OPG study]6.5562166
GSM549122patient 082, normal, homogenized [OPG study]7.5198277
GSM549134patient 033, cancer, homogenized [OPG study]5.2623346
GSM549136patient 036, cancer, homogenized [OPG study]4.8762739
GSM549140patient 044, cancer, homogenized [OPG study]5.5050950
GSM549111patient 047, normal, homogenized [OPG study]6.5033265
GSM549113patient 057, normal, homogenized [OPG study]7.0695572
GSM549132patient 031, cancer, homogenized [OPG study]4.63533
GSM549137patient 038, cancer, homogenized [OPG study]4.5811231
GSM549142patient 047, cancer, homogenized [OPG study]5.6321250
GSM549100patient 110, normal, homogenized [OPG study]5.9249857
GSM549107patient 135, normal, homogenized [OPG study]6.5112366
GSM549115patient 068, normal, homogenized [OPG study]6.5826866
GSM549116patient 072, normal, homogenized [OPG study]6.4342264
GSM549120patient 078, normal, homogenized [OPG study]6.3541263
GSM549131patient 030, cancer, homogenized [OPG study]5.3235348
GSM549118patient 074, normal, homogenized [OPG study]6.3728263
GSM549129patient 027, cancer, homogenized [OPG study]4.5026229
GSM549123patient 088, normal, homogenized [OPG study]6.6756668
GSM549124patient 006, cancer, homogenized [OPG study]5.7329553
GSM549126patient 015, cancer, homogenized [OPG study]7.6164578
GSM549128patient 025, cancer, homogenized [OPG study]6.9718370
GSM549103patient 117, normal, homogenized [OPG study]7.0595673
GSM549117patient 073, normal, homogenized [OPG study]6.9731172
GSM549138patient 041, cancer, homogenized [OPG study]7.1042372
GSM549141patient 045, cancer, homogenized [OPG study]5.2899847
GSM549130patient 028, cancer, homogenized [OPG study]5.3430547
GSM549101patient 111, normal, homogenized [OPG study]7.4254776
GSM549105patient 128, normal, homogenized [OPG study]7.299975
GSM549106patient 134, normal, homogenized [OPG study]9.4276990
GSM549112patient 048, normal, homogenized [OPG study]7.3259375
GSM549125patient 011, cancer, homogenized [OPG study]5.9724958
GSM549127patient 024, cancer, homogenized [OPG study]6.7327567
GSM549135patient 035, cancer, homogenized [OPG study]4.8016637